Click here to view First issue of IJUTM June 2024



About IJUTM


The International Journal of Unani and Traditional Medicine (IJUTM) represents a beacon of scholarly excellence and intellectual inquiry in the realm of traditional medicine. Published by the Federation of Holistic & Traditional Medicine (FHT), IJUTM is a premier open-access, peer-reviewed journal that upholds rigorous academic standards. It serves as a platform for pioneering research and scientific discourse, embodying the FHT's dedication to advancing traditional medicine with global scientific recognition.

Publication Details:


Journal Title: International Journal of Unani and Traditional Medicine (IJUTM)
Starting Year of Publication: 2024
Frequency of Publication: Three issues per year
Format of Publication: Online
Subject: Biological Sciences (General)
Language: English
ISSN: 3048-9482

Our Board

Mr S Sathyamoorthy(IAAS-R)

Chairman, Federation of Holistic Health and Traditional Medicine (FHT)

"Mr Sathyamoorthy is the former Deputy Comptroller & Auditor General of India. He is also the CEO of India's Anti-Corruption Academy(ACA). He is the Chairman of the Federation of Holistic Health and Traditional Medicines."

Mr. Umar Siddiqui

MD,Federation of Holistic Health & Traditional Medicines(FHT)

Mr Siddiqui is a global entrepreneur, educationist and Startups promoters. He is the patron of FHT Journal. He is the CMD of GlobalPact International Holdings, a diversified business group. He is the Founding MD of FHT, the first integrated Federation of Holistic Health & Traditional Medicines in the country.

Prof. Retd. Shakir Jamil

Chairman - Editorial Board

Prof. Shakir Jamil has rendered his services to Unani medicine as a teacher, researcher, and clinician for the last 45 years, starting at the University of Delhi and then at Jamia Hamdard. He has been involved in the regulation of Unani education in India as a member and expert of the Central Council of Indian Medicine (CCIM), which is constituted for syllabi and curriculum development.

Prof. K.M.Y. Amin

A.M.U. Aligarh

Prof. KMY Amin is a medical pharmacologist who completed his MBBS & MD (Pharmacology) from AMU. He was the Professor in Pharmacology teaching Modern Pharmacology and Research Methods in the Faculty of Unani Medicine of Aligarh Muslim University (AMU) to MD (Unani) students for the last 30 years and supervised Experimental & Clinical Pharmacological research on Unani Drugs in more than 50 MD(Unani), PhD & Post-Doctoral Projects in AMU, Hamdard University, New Delhi, National Institute of Unani Medicine, Bangalore etc.

Prof. Asia Sultana

(Former Chairperson of Ilaj Bit Tadbeer, AMU, Aligarh)

Prof. Asia Sultana, former chairperson, Dept. of Ilaj-bit-Tadbeer, Faculty of Unani Medicine, Aligarh Muslim University, Aligarh, is a prolific academician and researcher with more than 23 years of experience, having served at Hamdard University previously and now at AMU.

MR. UPDESH MADAN

DIRECTOR-CORPORATE GOV & FIN (FHT)

" Mr Updesh Madan is a senior banker and compliance expert. He has been with India's national banking group State Bank and its affiliated groups for almost 40 years. Mr Madan is the Director(Corporate Governance and Compliance) of FHT. "

DR. M. A. MUFAZZAL

(SENIOR RESEARCHER)

" Dr M A Mufazzal is an acclaimed academician and researcher. He is the Director of Federation of Holistic Health and Traditional medicines(FHT). He has done his doctorate from Jawaharlal Nehru University. "

Dr. Jamal Akhtar

R.O. (S4), CCRUM, New Delhi

Dr. Jamal Akhtar has done his MD in Unani Medicine from Jamia Hamdard, New Delhi. He has also completed a PG Diploma in Health and Family Welfare Management from NIHFW, New Delhi. He is serving as Research Officer, Scientist IV, in the Central Council for Research in Unani Medicine, Ministry of Ayush, Government of India.

Dr. Abu Kashif Anwar

(HSZH Govt. Unani Medical College and Hospital, Bhopal)

Dr. A. Kashif Anwar did his bachelor's in Unani medicine and surgery (2003) and MD in Kulliyat/Basic Principles (2008) from AMU Aligarh, UP, India. He is an assistant professor at the Govt. Unani Medical College and Hospital in Bhopal, which is affiliated with MP Medical Science University, Madhya Pradesh, India.

Dr. S.M. Abbas Zaidi

HSZH Govt. Unani Medical College and Hospital, Bhopal

Dr. Syed Mohammad Abbas Zaidi completed his B.U.M.S. and M.D. degrees in the Unani System of Medicine from Hamdard University, New Delhi, and is currently working as an assistant professor at H.S.Z.H. Govt. Unani Medical College, Bhopal (India).

Dr. Mohammad Yasir

MD, PhD, Asst. Prof. Dept. of Ilmul Amraz, AMU, Aligarh

Dr. Mohammed Yasir is an alumnus of the NIUM, Bangalore, and Jamia Millia Islamia, New Delhi, holding distinctions throughout his academic career. His areas of interest are Unani fundamentals and neuropsychiatric disorders with 15 years of experience in Unani medical practice, education, and research.

FOR AUTHORS

Peer review process

 (IJUTM) is a peer-reviewed journal. Manuscripts should impart novel findings addressing significant questions in Unani and other fields of traditional medicine, and should not be published or considered for publication elsewhere. After an initial review by our editorial board, all articles will be sent out for review by external reviewers. The acceptance criteria are the quality and originality of the research and its significance to our readership.

Publication Ethics

Publication ethics and malpractice statement

Authors are expected to maintain the ethical standards and conduct that remain mandatory in scholarly publishing. During the submission, authors need to state that their work has not been submitted elsewhere.

Guidelines for Authors


  • All authorships should be decided and agreed upon prior to submission of the manuscript, and the written consent of the corresponding author is a must. The responsibility for obtaining the consent of other co-authors will lie with the corresponding author. By giving the consent of the corresponding author, it will be assumed that the corresponding author has obtained the consent of all the contributing authors on his own.
  • Tables in limited numbers should be submitted with the captions placed above. Do not submit tables as photographs. Each table should be typed on a separate sheet of paper. Tables should be provided with headings, kept as simple as possible, and referred to in the text as "Table 1". Place explanatory matters in footnotes, not in the heading.
  • Figures (including photographic prints, line drawings on strong white or transparent paper, and maps) should be in limited numbers and numbered accordingly. Graphs and diagrams should be large enough to permit reduction to a required size; legends for figures should be listed accordingly on a separate sheet of paper. Photograph quality should be standard and clear. The captions should be placed below.
  • Bibliographical reference should be listed in an alphabetical order of the author at the end of the paper. Authors should be cited in the text only by their surnames, but their initials should be shown in the bibliography. References to the journal should include the name(s) and initial(s) of the author(s), year of publication, title of book, journal, title of the article, volume number (Arabic numerals), issue number where appropriate, and first and last page numbers. References to books should include the names and initials of the authors, the year of publication, the exact title, the names of the publisher, the place of publication, and the page number. Reference should be cited in the text in parentheses by the name(s) of the author(s) followed by the year of publication, e.g., "(Jain)," except when the author’s name is part of the sentence, e.g., "Jain (1991) has reported that. If there are more than two authors, it is in order to put "et al." After the first name, e.g., Khan et al., 1981.
  • Abbreviations and symbols must be in standard form. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
  • Acknowledgement of all the contributors in the research works whether individual or organization having any kind of support from planning till reporting stage is necessary.Authors must use inclusive language in their manuscripts especially in gender background.

Responsibilities of Author

Reporting standards

Authors of reports of original research should present an accurate kind of work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.

Originality and Plagiarism

The authors should ensure that they have written entirely original works, and if they have used the work and/or words of others, that this has been appropriately cited or quoted. Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper to copying or paraphrasing substantial parts of another’s paper (without attribution) to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable.

Multiple, Redundant, or Concurrent Publication

An author should not, in general, publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

Acknowledgment of Sources:

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, such as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Disclosure and Conflicts of Interest:

All authors should disclose in their manuscript any financial or other substantive conflicts of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published work

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and co-operate with the editor to retract or correct the paper.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, as submissions may be returned to authors who do not adhere to these guidelines.

The submission should not have been previously published, nor is it before another journal for consideration (an explanation may be provided in Comments to the Editor).

Cover letter: This should include 3 preferred reviewers (full contact details).

Indicate the main area(s) (e.g., Unani Medicine or name of other traditional medicine, phytochemistry, phytopharmacology, clinical, observational study, etc.) in which your paper better fits in.

The size and format of the manuscript Top and bottom margins: 2.54 cm; left and right sides: 3.18 cm. Double-spaced with a sample margin on all sides Page numbers and line numbers should be added to the manuscript. While submitting a paper, the corresponding author should ensure that his/her complete correspondence address, along with the email ID, mobile number, and affiliation of every author, has been included in the manuscript.

FOR REVIEWERS

Guidelines for Reviewers

  • The paper(s) should be submitted through email, and the expert should ensure the confidentiality of the paper being referred to him/her.
  • The expert should advise the editor whether the article referred to fulfills the requirements of scientific writing for publication, for example, the title, objectives, material and methods, statistical clarity, findings, and discussion, citation of references, etc.
  • The expert's comments on a particular paper should be precise and focused, and clear-cut directions should be given as to whether the article should be accepted as such, revised, or rejected, preferably with supporting arguments.
  • In case, the expert is pre-occupied with other assignments, he/she may feel free to return the article without comments.
  • The expert is expected to return the paper within a fortnight from the date of receipt.
  • In case, the paper referred to an expert is not in his/her area of specialization, he/she may feel free to return it without comments.

Types of paper

Contributions falling into the following categories will be considered for publication:

Editorials are written by the Editorial Board member or by guest editorials specially invited by the Editor-in-chief. Restrict the manuscript to about 1500 words and up to 15 references.

Studies involving integrative methods and techniques for the standardization of drugs and the diagnosis of diseases based on Unani classical guidelines will be appreciated. Please restrict the structured abstract to 300 words (background, objectives, material and methods, results, and conclusions) and the manuscript to about 6,000 words. Authors should mention details of the authentication of raw drugs and finished formulations used and animal ethics committee clearance (if applicable).

Research conducted on humans should be in compliance with the Declaration of Helsinki and the principles of good clinical practice wherever applicable. Approval of research by the relevant ethics committee is mandatory and should be mentioned wherever applicable. The revised CONSORT guidelines should be followed, and the protocol and completed CONSORT checklist must be submitted along with the manuscript. Clinical trials done in India should be registered first on the Clinical Trials Registry of India (CTRI), and articles from other countries must also fulfill the criteria of similar trial registration (as officially required in their own countries) because no RCT article is accepted unless it contains the official registered code.

Systematic reviews should be presented in the Introduction, Methods, Results, and Discussion format. The subject must be clearly defined. The objective of a systematic review should be to arrive at an evidence-based conclusion. The Methods section should give a clear indication of the literature search strategy, data extraction procedure, grading of evidence, and kind of analysis used. We strongly encourage authors to comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Case studies concern the successful application of treatment, adverse events, or novel observation of a single case. The cases should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Restrict the manuscript to about 1,500 words (excluding references) and include a non-structured abstract of up to 200 words.

Short communications may include important preliminary studies and reports. Please provide non-structured abstract to 250 words and restrict the manuscript to about 1,500 words.

A good review article may have author(s) claim / view after going through scientific literature pertaining to a specific area, reasons behind the claim / view, factual evidences discussing the claim / view and finally novel conclusions drawn after interlinking many research findings. Restrict non-structured abstract to 250 words and manuscript to about 6000 words.

 Book reviews can be solicited by editorial staff or commissioned. ones Readers are welcome to suggest high-quality contemporary or historically important books on the Unani system of medicine as well as other recognized traditional systems of medicine for review.